CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 16, 2005--Correlagen Diagnostics, Inc. and Cerner Corporation announced today that they have signed an agreement that will enable Cerner’s clients to order Correlagen’s genetic tests and to receive results through Cerner Millennium(R) and other Cerner(R) solutions. Correlagen Diagnostics, a clinical reference laboratory, develops and performs DNA sequence based testing for genes where variation is correlated with disease, and knowledge of patient genotype facilitates diagnosis and treatment. Correlagen uses a unique dynamic approach to genetic testing, which includes providing updated interpretations of patient results as the knowledge of genetic variation and its significance to diagnosis and treatment evolves.
